WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$85.99
−1.60%Year over year
Reported trailing growth
- Revenue
- +25.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +18.7%
- EBITDA
- +171.5%
- EPS
- +118.0%
Three-year CAGR
- Revenue
- +22.1%
- EBITDA
- +124.0%
- EBIT
- +49.2%
- Net income
- +59.8%
- EPS
- +62.4%
- Free cash flow
- +142.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026